跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
热珀西亚 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ozanimod Hydrochloride Capsules
Approved
化学药品
Ozanimod Hydrochloride Capsules
Bristol-Myers Squibb Pharma EEIG
🇨🇳 National Medical Products Administration
Approval Date
Jan 31, 2023
Approval ID
dce45fe984e85c39
Company
Bristol-Myers Squibb Pharma EEIG
Type
化学药品
Approval Details
Approval Id
dce45fe984e85c39
Approval Number
国药准字HJ20230004
Generic Name
盐酸奥扎莫德胶囊
Generic Name En
Ozanimod Hydrochloride Capsules
Trade Name
热珀西亚
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
0.23mg(按C₂₃H₂₄N₄O₃计)
Reg Date
2023-01-31
Expired Date
2028-01-30
Company Name
Bristol-Myers Squibb Pharma EEIG
Production Company Name
Celgene International SARL
Company Detail Path
/organization/bristol-myers-squibb-pharma-eeig
Production Company Detail Path
/organization/celgene-international-sarl-belgium
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 31, 2023
Approval ID
dce45fe984e85c39
Type
化学药品
Back to NMPA Approvals